Giovanna Gallo

Pubblicazioni

Titolo Pubblicato in Anno
The natriuretic peptides for hypertension treatment HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2022
Endothelial Dysfunction in Hypertension. Current Concepts and Clinical Implications FRONTIERS IN MEDICINE 2022
Hypertension and COVID-19. Current Evidence and Perspectives HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2022
Exercise oxygen pulse kinetics in patients with hypertrophic cardiomyopathy HEART 2022
Relationship Between Cardiorespiratory Fitness, Baseline Blood Pressure and Hypertensive Response to Exercise in the Ferrari Corporate Population HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2022
Impact of a NDUFC2 Variant on the Occurrence of Acute Coronary Syndromes FRONTIERS IN CARDIOVASCULAR MEDICINE 2022
Myocardial Infarction in Patients Without Cardiovascular Risk Factors: Advanced Prediction Models to Unlock the Clinical Dilemma? JACC. CARDIOVASCULAR INTERVENTIONS 2022
β-Blockers and Erectile Dysfunction in Heart Failure. Between Myth and Reality REVIEWS IN CARDIOVASCULAR MEDICINE 2022
Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations VASCULAR HEALTH AND RISK MANAGEMENT 2022
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2022
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY 2022
Features and follow-up of patients affected by noninflammatory myocarditis after coronavirus disease 2019 vaccination JOURNAL OF CARDIOVASCULAR MEDICINE 2022
Endocrine functions of the heart: from bench to bedside EUROPEAN HEART JOURNAL 2022
ARB-Based Combination Therapy for the Clinical Management of Hypertension and Hypertension-Related Comorbidities: A Spotlight on Their Use in COVID-19 Patients HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company JOURNAL OF HUMAN HYPERTENSION 2021
Insights from cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy BIOMOLECULES 2021
Insights from Cardiopulmonary Exercise Testing in Pediatric Patients with Hypertrophic Cardiomyopathy BIOMOLECULES 2021
A plea for smoking-free policies in COVID-19 times: cardiovascular prevention as an ally in coronavirus containment HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION 2021
A Contemporary View of Natriuretic Peptides in the SARS-CoV-2 Era FRONTIERS IN PHYSIOLOGY 2021
Sacubitril/Valsartan as a therapeutic tool across the range of Heart Failure phenotypes and ejection fraction spectrum FRONTIERS IN PHYSIOLOGY 2021

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma